Our purpose was to see how other biomarkers, CEA, CA125, and AFP, and blood parameters of parathyroid and thyroid glandular dysfunction interplay with CA15-3, the most commonly used tumor marker in breast cancer. Here, MUC16 is linked to breast carcinoma.